Similarly, others have shown that pre-treatment samples obtained from responders to anti-PD1 therapy showed that increased amounts of CD8-, PD-1- and PD-L1+ cells resided at the invasive tumor margins and within the tumor, with close proximity the ligands PD-1 and PD-L1 (24). The gene discussed is CD8A; the disease is neoplasm.